Skip to main content

Coronavirus (COVID-19): Latest Updates | Visitation PoliciesVisitation PoliciesVisitation PoliciesVisitation PoliciesVisitation Policies | COVID-19 Testing | Vaccine InformationVaccine InformationVaccine Information

menu

Funding

Clinical & Translational Science Institute / Funding / Equity-Focused Dissemination and Implementation Pilot Award

Equity-Focused Dissemination and Implementation Pilot Award

These pilot awards stimulate early phase research that incorporates elements of health equity-focused dissemination and implementation science (EQ-DI). EQ-DI is the science and practice of effective translation, distribution, and use of evidence-based interventions and policies in real-world settings, with an explicit focus on addressing health inequities.

Learn more about the UR CTSI's EQ-DI program. 

This funding opportunity is not currently open.

Notify When Available

Return to: Funding Directory

Eligibility

One of the members of the applying team must have a faculty appointment at the University of Rochester. This team member will be the contact PI for the project. We strongly encourage collaboration with health systems, community-based agencies, and other entities. Faculty may participate as PI or MPI on only one submission. Faculty may participate in multiple submissions per category as co-investigator.

Eligible Clinical Trials: The National Center for Advancing Translational Sciences (NCATS) can only provide direct support for clinical trials ranging from Phase 1 through Phase 2A; Phase 2B clinical trials or those of subsequent phases are not eligible. NCATS defines Phase 2 clinical trials as those that are designed to test drugs for efficacy and side effects in a limited number of patients. Phase 2A trials provide data for exposure-response in patients, while Phase 2B trials provide data for dose-ranging in patients.

Funding Amount

These awards provide up to $30,000 over 11 months.

Important Dates

The following dates apply to the most recent solicitation:

  • Release date - February 26, 2024
  • Proposals due  - April 1, 2024
  • Notifications of award  - May 27, 2024
  • Anticipated start date - August 1, 2024
  • End date - June 30, 2025 (all project activities and spending must be completed by this date)

Contact

If you have questions regarding this RFA, please contact one of the following:

General inquiries 
Karen Vitale, karen_vitale@urmc.rochester.edu

Scientific and Peer Review
Kevin Fiscella, M.D., M.P.H., Kevin_Fiscella@URMC.Rochester.edu
James McMahon, Ph.D., James_Mcmahon@URMC.Rochester.edu
Reza Yousefi Nooraie: M.Sc., Ph.D., Reza_Yousefi-nooraie@URMC.Rochester.edu

Financial inquiries 
Mary Lyons mary_lyons@urmc.rochester.edu

Apply

Read and use these documents to apply:
EQ-DI Pilot RFA 2024
CTSI Signoff Form 11/2021

Please note that UR CTSI awards and funding are dependent upon the renewal of grants from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH).

Ready to Apply?

Start Application

Notify When Available

This funding opportunity is not currently open. Complete the form below to be notified when it is available again.

Notify Me About: